HPS Pharmacies wish to give notice that Amdipharm Mercury is anticipating a supply interruption for tranylcypromine tablets as follows:
Parnate® is expected to be in short supply between 1 November 2020 and 7 December 2020. An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989, and may be dispensed under the Pharmaceutical Benefits Scheme (PBS).
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Amdipharm Mercury on (02) 9431 6333 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates